Product Brief
Retatrutide represents the next generation of incretin peptides, activating GLP-1, GIP, and glucagon receptors in a single molecule. It is sought after for comprehensive metabolic and body-composition protocols.
As a triple agonist at GLP-1, GIP, and glucagon receptors, Retatrutide represents the cutting edge of incretin science — offering the most comprehensive metabolic receptor coverage available in a single peptide molecule.
Every Radiptide batch is manufactured under strict quality control and tested for identity and purity. Certificate of Analysis (COA) available on request.